The past two trading days were rough for vaccine-maker Novavax (NVAX) and its investors. The stock has plunged nearly 30% on the news of a new Russian rival. In a statement reported out of Russian news agency RIA Novosti, Russian President Vladimir Putin announced that Russian researchers have “registered” the world’s first vaccine against infection with the novel coronavirus, that full-scale production will begin in September, and distribution in October. President Putin is so optimistic about the new vaccine — dubbed “Sputnik V” to hark back to Russia’s “Sputnik moment” in 1957, when Russia orbited the world’s first satellite — …read more
Source:: Yahoo Finance
